TII INDUSTRIES INC
SC 13D/A, 1995-10-05
SWITCHGEAR & SWITCHBOARD APPARATUS
Previous: TII INDUSTRIES INC, SC 13D/A, 1995-10-05
Next: TII INDUSTRIES INC, SC 13D/A, 1995-10-05









                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  SCHEDULE 13D

                    Under the Securities Exchange Act of 1934
                                (Amendment No. 1)

                              TII Industries, Inc.
                                (Name of issuer)

                          Common Stock, $.01 par value
                         (Title of Class of Securities)

                                   872479 20 9
                                 (CUSIP Number)

                                Leonard W. Suroff
                            c/o TII Industries, Inc.
                                1385 Akron Street
                            Copiague, New York 11726
 (Name, address and telephone number of person authorized to receive notices and
                                 communications)

                                  June 1, 1993
             (Date of event which requires filing of this statement)

If  the filing person has previously filed a statement on Schedule 13G to report
the  acquisition  which  is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box   

Check  the following box if a fee is being paid with the statement  .  (A fee is
not  required only if the reporting person: (1) has a previous statement on file
reporting  beneficial  ownership  of  more  than  five  percent  of the class of
securities  described  in  Item  1;  and  (2)  has filed no amendment subsequent
thereto  reporting  beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)











                               Page 1 of  7 Pages<PAGE>





 CUSIP No. 872479 20 9                                        Page 2 of 7 Pages



Response to Question   1:     Leonard W. Suroff
Response to Question   2:     N/A
Response to Question   3:     SEC USE ONLY
Response to Question   4:     PF
Response to Question   5:     N/A
Response to Question   6:     United States
Response to Question   7:     130,000
Response to Question   8:     0
Response to Question   9:     130,000
Response to Question   10:    0
Response to Question   11:    130,000
Response to Question   12:    N/A
Response to Question   13:    3.4%
Response to Question   14:    IN<PAGE>





 CUSIP No. 872479 20 9                                        Page 3 of 7 Pages


      This  amendment  to  the  Schedule 13D (the "Statement") is being filed by
Leonard  W.  Suroff to reflect that he ceased to be the beneficial owner of more
than  5% of the Company's Common Stock on June 1, 1993.  This statement restates
(except  for  previously  filed  paper exhibits) the entire text of the Schedule
13D.    Except  as  stated below, the disclosure in this Statement regarding Mr.
Suroff's  ownership  of  the  securities  of  TII  Industries,  Inc., a Delaware
corporation  (the  "Company"),  speaks  as  of June 1, 1993, the date Mr. Suroff
ceased  to  be  the    beneficial  owner of more than 5% of the Company's Common
Stock.

      In  April  the  Company  1994  the  issuer  of  the security to which this
Statement pertains effected a 1 for 2  1/2  reverse stock split of the Company's
Common  Stock  and  Class  B  Stock.  All disclosure in this Statement regarding
stock ownership and per share amounts reflect post-split numbers.

Item 1.     Security and Issuer.

      This  Statement  relates  to  the  Common  Stock, $.01 par value per share
("Common  Stock"),  of  the  Company.    The  principal executive offices of the
Company are located at 1385 Akron Street, Copiague, New York 11726.

Item 2.     Identity and Background.

(a)   This Statement is being filed by Leonard W. Suroff.

(b)   The business address of Mr. Suroff is c/o TII Industries, Inc., 1385 Akron
      Street, Copiague, New York 11726.

(c)   Mr.  Suroff  is an attorney admitted to practice in the State of New York.
      Mr.  Suroff  is  employed  as  counsel by the Company and also by American
      Biogenetic Sciences, Inc ("ABS").

      The Company is a leading supplier to the United States telephone operating
      companies of overvoltage surge protectors.

      ABS  conducts  research  and  development  of  therapeutic  and diagnostic
      products in the area of blood coagulation and human cancer. 

      The  Company's  principal  executive  offices  are  located  at 1385 Akron
      Street, Copiague, New York 11726.

      ABS's  principal  executive  offices  are  presently located at 1539 North
      Ironwood Drive, South Bend, Indiana 46635.

(d)   During the last five years Mr. Suroff has not been convicted in a criminal
      proceeding<PAGE>





 CUSIP No. 872479 20 9                                        Page 4 of 7 Pages


(excluding traffic violations or similar misdemeanors).

(e)   During  the  last  five  years, Mr. Suroff has not been a party to a civil
      proceeding  of a judicial or administrative body of competent jurisdiction
      and as a result of such proceeding was or is subject to a judgment, decree
      or final order enjoining future violations of, or prohibiting or mandating
      activities  subject  to,  federal  or state securities laws or finding any
      violation with respect to such laws.

(f)   Mr. Suroff is a citizen of the United States.

Item 3.     Source and Amount of Funds or Other Consideration.

      In the original Schedule 13D, dated October 31, 1992 ("Original 13D"), Mr.
Suroff  reported  that  he  had  expended $250,000 of his personal funds for the
purchase  of  2,500  shares  of  the Company's Series B Cumulative 10% Preferred
Stock  (the  "Series B Preferred Stock").  Effective August 7, 1992, the Company
completed  a  private placement (the "Private Placement") of 2,200,000 shares of
Common  Stock  and warrants (the "Warrants") to purchase a like number of shares
of  Common  Stock.  Included in such shares and Warrants was the issuance to Mr.
Suroff  of  100,000  shares  and Warrants to purchase a like number of shares of
Common  Stock  in exchange for the 2,500 shares of the Series B Preferred Stock.
The  Warrants entitled the holders thereof to purchase Common Stock until August
6, 1995 at an exercise price of $5.00 per share of Common Stock.  

Item 4.     Purpose of Transaction.

      The  securities  of  the  Company held by Mr. Suroff were acquired and are
being  held,  as  an  investment.   Mr. Suroff has no present plans or proposals
which  relate  to or would result in:  (a) the acquisition or disposition by any
person  of additional securities of the Company (although Mr. Suroff retains the
right,  which  he  may  exercise  at  any  time  or  from  time  to time, in his
discretion,  to  exercise  the stock options owned by him or to purchase or sell
equity  securities  of  the  Company  in  open market or in privately negotiated
transactions  as  circumstances  warrant),  (b)  an  extraordinary  corporate
transaction,  such  as  a  merger,  reorganization or liquidation, (c) a sale or
transfer  of  a  material  amount  of  assets  of  the  Company  or  any  of its
subsidiaries,  (d) any change in the present board of directors or management of
the  Company,  including  any plans or proposals to change the number or term of
directors  or  to  fill  any  existing  vacancies on the board, (e) any material
change  in the present capitalization or dividend policy of the Company, (f) any
other  material change in the Company's business or corporate structure, (g) any
change in the Company's charter, by-laws or instruments corresponding thereto or
other  actions which may impede the acquisition of control of the Company by any
person,  (h)  causing a class of securities of the Company to be delisted from a
national  securities  exchange  or  cease  being  authorized  to be quoted in an
inter-dealer  quotation  system of a registered national securities association,
(i)  a  class  of  equity  securities  of  the  Company  becoming  eligible  for
termination  of  registration  pursuant  to  Section  12(g)(4) of the Securities
Exchange Act of 1934 or (j) any action similar to any of those enumerated above.
<PAGE>





 CUSIP No. 872479 20 9                                        Page 5 of 7 Pages


Item 5.     Interest in Securities of the Issuer.

(a)  & (b)  The  following  table  sets  forth  the  beneficial  ownership  and
            information  concerning  voting  and dispositive power of Leonard W.
            Suroff.    The  disclosure  speaks  as of June 1, 1993, the date Mr.
            Suroff  ceased  to  be  the  beneficial owner of more than 5% of the
            Company's Common Stock:

                                                Number of           Period of
                              Name              Shares(1)           Class (2)

                        Leonard W.              130,000(3)          3.4%(4)     
                        Suroff
                                    
            (1)   Mr.  Suroff has sole voting and dispositive power with respect
                  to the shares owned by him.

            (2)   Percent of Class assumes the issuance of Common Stock upon the
                  exercise of options (to the extent exercisable on or within 60
                  days  of June 1, 1993) deemed beneficially owned by Mr. Suroff
                  but by no other person or entity.

            (3)   Includes  (a)  60,000  outstanding  shares  and  60,000 shares
                  issuable  upon  exercise of Warrants which were exercisable in
                  full  on June 1, 1993; and (b) 10,000 shares issuable upon the
                  exercise  of  the  portion of options held under the Company's
                  1986  Stock Option Plan which were exercisable on or within 60
                  days of June 1, 1993.

(c)   (i)   In  the  Original  13D, Mr. Suroff reported that effective August 7,
            1992,  the  Company  completed the Private Placement of, among other
            securities, 2,200,000 shares of Common Stock and Warrants.  Included
            in  such Common Stock and Warrants was the issuance to Mr. Suroff of
            100,000  shares  of  Common  Stock  and  Warrants to purchase a like
            number  of  shares  of  Common Stock in exchange for 2,500 shares of
            Series  B Preferred Stock.  The 2,500 shares of the Company's Series
            B  Preferred  Stock had been acquired by Mr. Suroff from the Company
            in a private placement on February 23, 1992 for $250,000. 

      (ii)  On  June  1,  1993,  Mr.  Suroff transferred 40,000 shares of Common
            Stock  and  Warrants to purchase 40,000 shares of Common Stock to an
            adult  son.  Mr. Suroff received no consideration for this transfer.
            While  Mr. Suroff's adult son lives in the same house as Mr. Suroff,
            Mr.  Suroff  does  not  have  the  power  to  direct  the  voting





 CUSIP No. 872479 20 9                                        Page 6 of 7 Pages

            or disposition of his adult son's securities.    Accordingly, Mr. 
            Suroff disclaims beneficial ownership of all securities owned by his
            son.  Since the time of the transfer, Mr. Suroff has not been a 
            beneficial owner of more than 5% of the Company's Common Stock.
 


(d)         No  other  person is known to have the right to receive or the power
            to  direct  the  receipt of dividends from, or the proceeds from the
            sale of, the Shares owned by Mr. Suroff.

Item 6.     Contracts,  Arrangements,  Understandings  or  Relationships  with
            Respect to Securities of the Issuer.

      As of June 1, 1993, Mr. Suroff held an option, granted under the Company's
1986  Stock  Option Plan on January 9, 1992, to purchase 20,000 shares of Common
Stock  at  an exercise price of $3.125 per share which option was exercisable as
to  5,000  shares,  on  a  cumulative basis, on each of January 9, 1993, July 9,
1993, January 9, 1994 and July 9, 1994.

            The  foregoing  summary of is qualified in its entirety by reference
to the exhibit to this Statement.

Item 7.     Materials to be Filed as Exhibits.

            1.    Stock  Option  Agreement  dated  January  9,  1992 between the
                  Company and Leonard W. Suroff.  Filed with the original 13D.<PAGE>





 CUSIP No. 872479 20 9                                        Page 7 of 7 Pages


                                    Signature

            After reasonable inquiry and to the best of the knowledge and belief
of  the undersigned, the undersigned certifies that the information set forth in
this Statement is true, complete and correct.

Dated:  October 2, 1995

                                                 /s/ Leonard W. Suroff          
                                                Leonard W. Suroff<PAGE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission